Wire · operational-macro
Anticipatory Assessment: A New Imperative for Responsible Biomedical Innovation
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 28 September 2026 · Fusion42 review
This article urges the adoption of anticipatory technology assessment in biomedical innovation to evaluate ethical, social, and safety risks early in development rather than near market entry. It argues for multisectoral governance and iterative assessments to guide responsible design decisions and prevent downstream harms in emerging health technologies.
This Wire brief sits within Fusion42's coverage of Healthtech Infrastructure.
◆ ◆ The Wire takeaway
You face growing pressure to integrate early, iterative assessments of ethical and social risks into biomedical product development. Building anticipatory risk evaluation into your design process can become a competitive advantage before regulators tighten oversight.
◆ Coverage
1 source · 28 Sep 2026
◆ Related on Wire
◆ Topics